Table 1 Comparison of clinical characteristics between ctEMVI positive group and ctEMVI negative group
ctEMVI positive (n = 77) | ctEMVI negative(n = 48) | t/χ2 value | P value | |
|---|---|---|---|---|
Age(year) | 64.6 ± 10.14 | 61.1 ± 10.71 | -1.846 | 0.067 |
Sex | 0.027 | 0.870 | ||
Male | 54(70%) | 33(69%) | ||
Female | 23(30%) | 15(31%) | ||
Tumor location | 3.287 | 0.193 | ||
Fundus | 15(19%) | 4(8%) | ||
Gastric body | 25(33%) | 15(31%) | ||
Gastric antrum | 37(48%) | 29(61%) | ||
Differentiation degree | 5.098 | 0.078 | ||
Low | 48(62%) | 21(44%) | ||
Medium | 27(35%) | 20(42%) | ||
High | 2(3%) | 7(14%) | ||
N staging | 42.010 | < 0.001 | ||
N0 | 5(6%) | 26(54%) | ||
N1 | 14(18%) | 10(21%) | ||
N2 | 20(26%) | 9(19%) | ||
N3 | 38(50%) | 3(6%) | ||
LVI | 61(79%) | 16(33%) | 26.321 | < 0.001 |
Tumor size (cm) | 22.770 | < 0.001 | ||
< 6 | 21(27%) | 34(70%) | ||
> 6 | 56(73%) | 14(30%) |